Diagnosis, screening, and management of cystic fibrosis-related diabetes.
Diagnosis, screening, and management of cystic fibrosis-related diabetes.
复制标题
DOI：
10.1007/s11892-002-0069-3
复制
发表时间：
2002-04-01
影响因子：
4.2
通讯作者：
Moran, Antoinette
中科院分区：
文献类型：
--
作者：
Moran, Antoinette
糖尿病是囊性纤维化(CF)的常见并发症，约40%的成人患者会发生糖尿病。它在临床上不同于1型或2型糖尿病，需要一种独特的治疗方法。由于有证据表明它与发病率和死亡率的增加有关，因此及时诊断和积极处理CF相关糖尿病(CFRD)是重要的。囊性纤维化基金会在1998年举行了一次协商一致的会议，确定了目前诊断和治疗这种疾病的标准。本文对这些建议进行了回顾，并提出了一种切实可行的面板堆石坝管理方法。
Diabetes is a common complication of cystic fibrosis (CF), occurring in approximately 40% of adult patients. It is clinically distinct from type 1 or type 2 diabetes, and requires a unique approach. Because of evidence that it is associated with increased morbidity and mortality, prompt diagnosis and aggressive management of CF-related diabetes (CFRD) is important. The Cystic Fibrosis Foundation held a consensus conference in 1998 to define the current standards for the diagnosis and care of this disease. This article reviews those recommendations, and presents a practical approach to the management of CFRD.